Recruiting

4

400

RoW

low-dose aspirin, conventional-does aspirin

Xijing Hospital, Shaanxi Provincial People's Hospital, The First Affiliated Hospital of Jiaotong University, Tang-Du Hospital, The First Affiliated Hospital of Xi'an Medical University, Xi'an Central Hospital, Xiangyang Central Hospital, Baoji Central Hospital

Ischemic Stroke

02/22

08/22

Recruiting

4

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

10/25

12/25

Completed

3

620

RoW

GLP-1 receptor agonist, Placebo, PB-119 Placebo

PegBio Co., Ltd.

Type 2 Diabetes Mellitus (T2DM)

09/22

05/23

Recruiting

3

204

RoW

Solriamfetol, Placebo

Ignis Therapeutics (Suzhou) Limited

Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea

09/24

10/24

Recruiting

3

1500

Europe, RoW

Donanemab, (LY3002813), Placebo

Eli Lilly and Company

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

04/27

04/27

Recruiting

2a

60

RoW

50561 high dose, 50561 low dose, Placebo

Beijing Joekai Biotechnology LLC

Alzheimer's Disease

05/24

06/24

Active, not recruiting

2

196

RoW

TCM Formula, RSYR decoction, Placebo, Placebo dicoction

Peking University Cancer Hospital & Institute

Cancer-related Problem/Condition

09/23

06/24

Recruiting

2

260

RoW

Placebo group, JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 low-dose group, JS1-1-01 pills; JS1-1-01 placebo pills; Duloxetine hydrochloride placebo capsules, JS1-1-01 pills; JS1-1-01 placebo pills, JS1-1-01 high-dose group, JS1-1-01 pills; Duloxetine hydrochloride placebo capsules, Active drug group, JS1-1-01 placebo pills; Duloxetine hydrochloride enteric coated capsule

Tasly Pharmaceutical Group Co., Ltd

Depression

04/25

04/25

Not yet recruiting

2

46

RoW

Relmacabtagene Autoleucel, JWCAR029, Fludarabine, Cyclophosphamide

Shanghai Ming Ju Biotechnology Co., Ltd.

Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma, Mediastinal B-Cell Diffuse Large Cell Lymphoma

08/24

02/27

Recruiting

1/2

100

RoW

Chidamide, epidaza, Cyclophosphamide, Epirubicin, Vindesine, Etoposide, Prednisone

Peking Union Medical College Hospital, Chinese PLA General Hospital, Peking University First Hospital, Peking University Third Hospital, Peking University Cancer Hospital & Institute, Tianjin Medical University Cancer Institute and Hospital

T Cell Non-Hodgkin's Lymphoma

03/20

03/23

Recruiting

1/2

46

RoW

Tislelizumab combined with Liposomal mitoxantrone hydrochloride, Maintenance of tislelizumab

Sun Yat-sen University

Extranodal Natural Killer T Cell Lymphoma

01/24

01/25

Completed

1

62

RoW

Jiedu Yizhi Formula, Donepezil Hydrochloride Tablets

Changchun University of Chinese Medicine

Ensure the Legality and Compliance of the Testing Process

12/23

04/24

Recruiting

1

10

RoW

Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes., Autologous Tris-CAR-T cell.

Beijing Tiantan Hospital, Beijing Neurosurgical Institute, Tasly Pharmaceutical Group Co., Ltd

Recurrent Glioblastoma

11/24

11/32

Active, not recruiting

N/A

3637

RoW

Changhai Hospital, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Coronary Arteriosclerosis

06/21

12/30

Active, not recruiting

N/A

3000

RoW

Changhai Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital

Coronary Artery Disease, Carotid Plaque

03/22

12/30

Recruiting

N/A

10254

RoW

Limeng Chen

Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder

12/24

12/24

Not yet recruiting

N/A

280

RoW

Methacholine Chloride

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Asthma

02/23

06/23

Recruiting

N/A

146

RoW

Acupuncture, basic therapy

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Acupuncture, Covid-19 Omicron, Pulmonary Function

04/23

04/23

Recruiting

N/A

159

RoW

electroacupuncture, acupuncture

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Erectile Dysfunction, Acupuncture Therapy, Median Nerve Disease

12/23

12/23

Recruiting

N/A

60

RoW

Changhai Hospital

Explore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases

12/23

12/24

Recruiting

N/A

20

RoW

[18F]AlF-NOTA-pentixather PET/CT, pathological examination

Sichuan Provincial People's Hospital

Aldosterone-Producing Adenoma

01/24

06/24

Recruiting

N/A

90

RoW

disc resection, segmental resection

Fudan University

Gastrointestinal Function, Quality of Life, Pregnancy Outcomes

12/24

12/24

Recruiting

N/A

570

RoW

Stent-based Diverting Technique

Sir Run Run Shaw Hospital

Rectal Neoplasms

12/24

06/25

Not yet recruiting

N/A

80

NA

Tilted Gaze Target Tast, Conventional Examination Methods

Tianjin Eye Hospital

Children With Torticollis

06/24

12/24

Active, not recruiting

N/A

10560

RoW

ctDNA methylation analysis by NGS

AnchorDx Medical Co., Ltd., Xiangya Hospital of Central South University, West China Hospital, Shanghai Zhongshan Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, First Hospital of China Medical University, Guizhou Provincial People's Hospital, Shanghai Chest Hospital, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital Xi'an Jiaotong University, Qilu Hospital of Shandong University, Inner Mongolia People's Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Zhengzhou University, Second Hospital of Jilin University, LanZhou University, Peking University Third Hospital, The First People's Hospital of Yunnan, Shantou Affiliated Hospital of Sun Yat-Sen University, Ruijin Hospital, The Shanghai Jiao Tong University Medical School, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Xijing Hospital, Air Force Medical University of PLA, Shenzhen People's Hospital, Henan Provincial People's Hospital, Beijing Chao Yang Hospital, Xiamen Second Hospital, The First Affiliated Hospital of Nanchang University

Pulmonary Nodules

09/24

06/25

Not yet recruiting

N/A

1000

RoW

Continuous Glucose Monitoring System (GX-01S)

Nanjing First Hospital, Nanjing Medical University

Type1 Diabetes Mellitus

10/26

06/27

Not yet recruiting

N/A

120

RoW

Angong Niuhuang Pill (ANP), Control (Standard treatment)

Nanjing Medical University, The First Affiliated Hospital with Nanjing Medical University, Beijing Anzhen Hospital, Capital Medicine University

Cardio-pulmonary Bypass, Cardiovascular Surgery, Cerebral Protection, Brain Injury

12/25

12/25

Recruiting

N/A

300

RoW

Follow up

Fujian Maternity and Child Health Hospital

Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions

12/25

05/26

Recruiting

N/A

46

RoW

Additional hCG injection, estrogen and dydrogesterone

Fudan University

Luteal Phase Deficiency, Luteal Phase Support, Idiopathic Hypogonadotropic Hypogonadism

12/25

12/25

Recruiting

N/A

100000

RoW

Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital

Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia

01/38

01/38

Active, not recruiting

N/A

3000

RoW

Changhai Hospital, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Coronary Artery Disease

12/21

12/30

Recruiting

3

1016

Europe, Canada, Japan, US, RoW

LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed

Eli Lilly and Company, Loxo Oncology, Inc.

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

10/26

10/29

Recruiting

2

60

Canada

Durvalumab, Prednisone, Tremelimumab

Canadian Cancer Trials Group, AstraZeneca

Cancer

04/30

04/31

Not yet recruiting

3

54

RoW

VC004 Capsules

Jiangsu vcare pharmaceutical technology co., LTD

Locally Advanced Solid Tumor

12/26

12/26

Recruiting

2a

80

RoW

Infigratinib, BGJ398

LianBio LLC

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Solid Tumor

12/22

12/23

2

51

RoW

Toripalimab, Docetaxel, Carboplatin

Sun Yat-sen University

Breast Cancer, Triple Negative Breast Cancer

Not yet recruiting

2

770

NA

Almonertinib 110 MG, HS-10296, AMEILE, Dacomitinib 45 MG, Vizimpro, Alectinib 150 MG, Alecensa, Crizotinib 250 MG, Xalkori, Pyrotinib 160/80 MG, SHR-1258, Imatinib 400 MG, Gleevec, Niraparib 200/300 MG, Niraparix, Palbociclib 125mg, Ibrance, Vemurafenib 240 MG, Zelboraf, Sintilimab 100MG, Tyvyt, Atezolizumab 1680 MG, TECENTRIQ

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Rare Tumor

07/22

07/23

Recruiting

2

115

RoW

VC004

Jiangsu vcare pharmaceutical technology co., LTD

Locally Advanced Solid Tumor, Metastatic Solid Tumor

01/24

06/24

Recruiting

2

10

RoW

LTC004+Toripalimab, LTC004 combine with Toripalimab

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Advanced Solid Tumor

03/26

03/26

Not yet recruiting

2

15

RoW

ES014, ES014 for Injection

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Elpiscience (Suzhou) Biopharma, Ltd.

Advanced Solid Tumor

06/26

09/26

Recruiting

1/2

320

RoW

TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab

Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb

Advanced Cancer

02/25

05/25

Recruiting

1/2

134

US, RoW

PRO1160

ProfoundBio US Co.

Renal Cell Carcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma

11/26

03/27

Recruiting

1/2

192

RoW

CT041 autologous CAR T-cell injection, CAR T-cell injection, Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）, Best support care(BSC)

CARsgen Therapeutics Co., Ltd., Peking University Cancer Hospital & Institute, Fudan University

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma

06/24

06/38

Recruiting

1/2

404

US, RoW

Genmab

Platinum-Resistant Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC), High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Breast Adenocarcinoma, Triple Negative Breast Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer

Recruiting

1

50

RoW

a CDK4 / 6 inhibitor and a MEK inhibitor

Henan Cancer Hospital

Digestive System Tumors

08/21

08/22

Recruiting

1

18

RoW

TC-N201 cells, IL-2, Fludarabine, Cyclophosphamide, Nab-paclitaxel

TCRCure Biopharma Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Advanced Solid Tumors

10/24

03/25

Recruiting

1

12

RoW

KSX01-TCRT cell therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Refractory Solid Tumors, Relapsed Solid Tumors

12/26

12/28

Recruiting

1

44

RoW

HS-IT101 Injection, HS-IT101

Qingdao Sino-Cell Biomedicine Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences, The First Hospital of Jilin University, West China Hospital

Solid Tumor

03/26

03/28

Recruiting

1

68

RoW

GH21 Capsule

Suzhou Genhouse Bio Co., Ltd.

Advanced Solid Tumor, Non-Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer, Head and Neck Neoplasm

12/24

02/25